Two Moderna Execs Allegedly Sold Off $30 Million In Stocks Amid Charges Of Over-Hyping Of COVID-19 Vaccine Trial
In the days following Moderna's announcement of the first round trials, the company made $1.3 billion in a sale of shares to the public. At the same time, two Moderna executives sold off nearly $30 million of their combined shares.